Advocacy Pays Off for ASCs

At the Outpatient Ophthalmic Surgery Society’s “OOSS Perspective 2026” symposium in Washington, DC, the organization's Washington counsel, Michael Romansky, JD, delivered an update on reimbursement, regulatory developments, and advocacy priorities affecting ophthalmic ambulatory surgery centers (ASCs).

By
Jennifer Ford, content director
Jennifer Ford, content director
May 1, 2026
4 min

Ophthalmology Management

1

Michael Romansky highlighted a 3.4% increase in ASC payments for 2026, reversing an initial proposed reduction, benefiting ASCs by approximately $150 million.
2

OOSS advocates for broader definitions of non-opioid drugs eligible for separate payment, aiming to include inflammation treatments in reimbursement policies.
3

The Outpatient Surgery Access Act of 2026 was introduced to address longstanding reimbursement concerns, encouraging OOSS members to advocate for its support.
4

OOSS emphasizes the importance of compliance with CMS regulations, warning that non-participation in prior-authorization projects may lead to non-payment.
5

Romanksy urged continued member engagement in advocacy, stating that visualizing ASC facilities can effectively communicate their value to legislators.

Advocacy Pays Off for ASCs

1

2

3

4

5

Original Source(s)

Advocacy Pays Off for ASCs

Related Content

2026 Coding Updates Impacting Ambulatory Surgical Centers

Why Smart Eye Surgeons Still Make Bad Growth Decisions

Medicontur Premium IOLs: Evidence-based excellence